1,084
Views
26
CrossRef citations to date
0
Altmetric
Editorial

The elvitegravir Quad pill: the first once-daily dual-target anti-HIV tablet

, PhD
Pages 901-904 | Published online: 10 May 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Satish Kumar Gupta & Nutan. (2013) Clinical use of vaginal or rectally applied microbicides in patients suffering from HIV/AIDS. HIV/AIDS - Research and Palliative Care 5, pages 295-307.
Read now
Rik Schrijvers & Zeger Debyser. (2012) Combinational therapies for HIV: a focus on EVG/COBI/FTC/TDF. Expert Opinion on Pharmacotherapy 13:13, pages 1969-1983.
Read now

Articles from other publishers (24)

Graziella Tocco, Serena Canton, Antonio Laus, Pierluigi Caboni, Stuart F. J. Le Grice, Enzo Tramontano & Francesca Esposito. (2023) Dihydroxyphenyl- and Heteroaromatic-Based Thienopyrimidinones to Tackle HIV-1 LEDGF/p75-Dependent IN Activity. Molecules 28:18, pages 6700.
Crossref
Maria Isaguliants, Olga Krotova, Stefan Petkov, Juris Jansons, Ekaterina Bayurova, Dzeina Mezale, Ilze Fridrihsone, Athina Kilpelainen, Philip Podschwadt, Yulia Agapkina, Olga Smirnova, Linda Kostic, Mina Saleem, Oleg Latyshev, Olesja Eliseeva, Anastasia Malkova, Tatiana Gorodnicheva, Britta Wahren, Ilya Gordeychuk, Elizaveta Starodubova & Anastasia Latanova. (2021) Cellular Immune Response Induced by DNA Immunization of Mice with Drug Resistant Integrases of HIV-1 Clade A Offers Partial Protection against Growth and Metastatic Activity of Integrase-Expressing Adenocarcinoma Cells. Microorganisms 9:6, pages 1219.
Crossref
Kenny Kuchta, Nguyen Huu Tung, Tomoe Ohta, Takuhiro Uto, Muhareva Raekiansyah, Kristina Grötzinger, Hans Rausch, Yukihiro Shoyama, Hans Wilhelm Rauwald & Kouichi Morita. (2020) The old pharmaceutical oleoresin labdanum of Cistus creticus L. exerts pronounced in vitro anti-dengue virus activity. Journal of Ethnopharmacology 257, pages 112316.
Crossref
Eloïse Thierry, Eric Deprez & Olivier Delelis. (2017) Different Pathways Leading to Integrase Inhibitors Resistance. Frontiers in Microbiology 7.
Crossref
Mathieu Métifiot, Barry C. Johnson, Evgeny Kiselev, Laura Marler, Xue Zhi Zhao, Terrence R. BurkeJrJr, Christophe Marchand, Stephen H. Hughes & Yves Pommier. (2016) Selectivity for strand-transfer over 3′-processing and susceptibility to clinical resistance of HIV-1 integrase inhibitors are driven by key enzyme–DNA interactions in the active site. Nucleic Acids Research 44:14, pages 6896-6906.
Crossref
Muriel Billamboz, Virginie Suchaud, Fabrice Bailly, Cedric Lion, Marie-Line Andréola, Frauke Christ, Zeger Debyser & Philippe Cotelle. (2016) 2-hydroxyisoquinoline-1,3(2 H ,4 H )-diones (HIDs) as human immunodeficiency virus type 1 integrase inhibitors: Influence of the alkylcarboxamide substitution of position 4. European Journal of Medicinal Chemistry 117, pages 256-268.
Crossref
Asma Khatri & Marion J Skalweit. (2014) A rare case of immune reconstitution inflammatory syndrome presenting as secondary syphilis. International Journal of STD & AIDS 26:10, pages 749-751.
Crossref
Miłosz Parczewski & Magdalena Witak-Jędra. (2015) Clinical data and practical experience related to Stribild as an option in patients with HIV infection. HIV & AIDS Review 14:4, pages 104-108.
Crossref
Pinar Iyidogan & Karen Anderson. (2014) Current Perspectives on HIV-1 Antiretroviral Drug Resistance. Viruses 6:10, pages 4095-4139.
Crossref
Major Gooyit, Nancy Tricoche, Sara Lustigman & Kim D. Janda. (2014) Dual Protonophore–Chitinase Inhibitors Dramatically Affect O. volvulus Molting . Journal of Medicinal Chemistry 57:13, pages 5792-5799.
Crossref
Virginie Suchaud, Fabrice Bailly, Cedric Lion, Christina Calmels, Marie-Line Andréola, Frauke Christ, Zeger Debyser & Philippe Cotelle. (2014) Investigation of a Novel Series of 2-Hydroxyisoquinoline-1,3(2 H ,4 H )-diones as Human Immunodeficiency Virus Type 1 Integrase Inhibitors . Journal of Medicinal Chemistry 57:11, pages 4640-4660.
Crossref
David B. Hanna, Nancy A. Hessol, Elizabeth T. Golub, Jennifer M. Cocohoba, Mardge H. Cohen, Alexandra M. Levine, Tracey E. Wilson, Mary Young, Kathryn Anastos & Robert C. Kaplan. (2014) Increase in Single-Tablet Regimen Use and Associated Improvements in Adherence-Related Outcomes in HIV-Infected Women. JAIDS Journal of Acquired Immune Deficiency Syndromes 65:5, pages 587-596.
Crossref
Weiwei Xue, Huanxiang Liu & Xiaojun Yao. (2014) Molecular Modeling Study on the Allosteric Inhibition Mechanism of HIV-1 Integrase by LEDGF/p75 Binding Site Inhibitors. PLoS ONE 9:3, pages e90799.
Crossref
Ole J Bjerrum, Yvonne Gautam, Per H Honoré & Vasiliki Vana. (2014) Drug–drug combinations revisited. European Journal of Hospital Pharmacy 21:1, pages 8-12.
Crossref
Qi Chen, John K. Buolamwini, Jeremy C. Smith, Aixiu Li, Qin Xu, Xiaolin Cheng & Dongqing Wei. (2013) Impact of Resistance Mutations on Inhibitor Binding to HIV-1 Integrase. Journal of Chemical Information and Modeling 53:12, pages 3297-3307.
Crossref
Soundasse Munir, Sylvain Thierry, Frédéric Subra, Eric Deprez & Olivier Delelis. (2013) Quantitative analysis of the time-course of viral DNA forms during the HIV-1 life cycle. Retrovirology 10:1.
Crossref
Jens-Uwe Peters. (2013) Polypharmacology – Foe or Friend?. Journal of Medicinal Chemistry 56:22, pages 8955-8971.
Crossref
Md. Hossain, Md. Ali & Cha-Gyun Shin. (2013) Structural and Functional Insights into Foamy Viral Integrase. Viruses 5:7, pages 1850-1866.
Crossref
Muriel Billamboz, Virginie Suchaud, Fabrice Bailly, Cedric Lion, Jonas Demeulemeester, Christina Calmels, Marie-Line Andréola, Frauke Christ, Zeger Debyser & Philippe Cotelle. (2013) 4-Substituted 2-Hydroxyisoquinoline-1,3(2 H ,4 H )-diones as a Novel Class of HIV-1 Integrase Inhibitors . ACS Medicinal Chemistry Letters 4:7, pages 606-611.
Crossref
Ole J. Bjerrum, Yvonne Gautam, Esben J. Bjerrum, Merete Schmiegelow & Harrie C.M. Boonen. (2013) Medicines combinations options and regulatory hurdles. European Journal of Pharmaceutical Sciences 49:4, pages 659-663.
Crossref
Brian A. Johns, Takashi Kawasuji & Emile J. Velthuisen. 2013. Successful Strategies for the Discovery of Antiviral Drugs. Successful Strategies for the Discovery of Antiviral Drugs 149 188 .
Peter K. Quashie, Thibault Mesplède & Mark A. Wainberg. (2013) Evolution of HIV integrase resistance mutations. Current Opinion in Infectious Diseases 26:1, pages 43-49.
Crossref
Weiwei Xue, Xiaojie Jin, Lulu Ning, Meixia Wang, Huanxiang Liu & Xiaojun Yao. (2012) Exploring the Molecular Mechanism of Cross-Resistance to HIV-1 Integrase Strand Transfer Inhibitors by Molecular Dynamics Simulation and Residue Interaction Network Analysis. Journal of Chemical Information and Modeling 53:1, pages 210-222.
Crossref
Mathieu Métifiot, Christophe Marchand & Yves Pommier. 2013. Antiviral Agents. Antiviral Agents 75 105 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.